Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality

• Status: Unknown status
• Trial end date: 2021-02-01
• Target enrollment: 0
• Participant gender: All

Summary

In this study we will assess the effect of Ketamine infusion on depressive symptoms and in particular its effect on Suicidal behavior, ideation and thoughts in patients with treatment- resistant MDD.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Ketamine

Criteria

Inclusion Criteria:

1. Patients fulfilling diagnostic criteria of treatment-resistant MDD.

2. Presence of suicidal risk.

3. No comorbid medical or neurological conditions.

4. Age above 18 years old.

5. Both gender.

6. Informed written consent from the patient or his legitimate.

Exclusion Criteria:

1. Presence of perceptual disturbance.

2. History of sensitivity to ketamine.

3. Refusal to participate in the study.